Epilepsy in Patients with Primary CNS Lymphoma, Prevalence, Risk Factors, and Prognostic Significance
Neurol 103:e209748, Aboubakr,O.,et al, 2024
The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1363-1374, Marson, A.,et al, 2021
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Results of Phase 2 Safety and Feasibility Study of Treatment with Levetiracetam for Prevention of Posttraumatic Epilepsy
Arch Neurol 69:1290-1295, Klein, P.,et al, 2012
Substitution Monotherapy with Levetiracetam vs Older Antiepileptic Drugs
Arch Neurol 69:1563-1571, Hakami, T.,et al, 2012
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects
JAMA 305:1996-2002, Molgaard, D. & Hviid, A., 2011
Comparative Effectiveness of 10 Antiepileptic Drugs in Older Adults With Epilepsy
Arch Neurol 67:408-415, Arif,H., et al, 2010
Response of Infantile Spasms to Levetiracetam
Neurol 70:574-575, Mikati,M.A.,et al, 2008
Tolerability and Efficacy of Oral Loading of Leviteracetam
Neurol 70:2166-2170, Koubeissi,M.Z.,et al, 2008
Levetiracetam as a Possible Cause of Fulminant Liver Failure
Neurol 71:685-686, Tan,T.C.H.,et al., 2008
Once-Daily Extended-Release Levetiracetam as Adjunctive Treatment of Partial-Onset Seizures in Patients with Epilepsy: A Double-Blind, Randomized, Placebo-Controlled Trial
Epilepsia 49:1-9, Peltola,J.,et al, 2008
Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007
Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007
Placebo-Controlled Study of Levetiracetam in Idiopathic Generalized Epilepsy
Neurol 69:1751-1760,1734, Berkovic,S.F.,et al, 2007
Levetiracetam in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 67:1876-1879, Hung,S.,et al, 2006
Levetiracetam for Seizures After Liver Transplantation
Neurol 64:1084-1085, Glass,G.A., et al, 2005
Use of Levetiracetam to Treat Tics in Chidlren and Adolescents With Tourette Syndrome
Movement Disorders 20:714-718, Awaad,Y.,et al, 2005
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Psychiatric Adverse Events During Levetiracetam Therapy
Neurol 61:704-706, Mula,M.,et al, 2003
Discontinuation of Levetiracetam Because of Behavioral Side Effects
Neurol 61:1218-1221, White,J.R.,et al, 2003
Drug Points
BJM 327:905, Hadjikoutis,S.,et al, 2003
A New Antiepileptic Drug
JNNP 72:426-429, Shorvon,S.D. &van Rijckevorsel,K., 2002
Improvement of a Patient with a Stuttering on Levetiracetam
Neurol 59:1288, Canevini,M.P.,et al, 2002
Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000
Levetiracetam for Partial Seizures: Results of A Double-Blind, Randomized Clinical Trial
Neurol 55:236-242, Cereghino,J.J. et al, 2000